Selank

Selank – Educational Overview

For Informational & Research Purposes Only.

What Is Selank?

Selank is a synthetic peptide developed from a fragment of the naturally occurring tetrapeptide tuftsin. It was originally created in Russia and has been investigated for its potential effects on anxiety modulation, cognitive function, and immune system support.

Selank is classified as a neuropeptide and is primarily studied in experimental and clinical research contexts. It is not approved by the U.S. Food and Drug Administration (FDA) for therapeutic use.

Research Background

Selank was developed by scientists at the Institute of Molecular Genetics. Research studies have explored its potential effects in areas such as:

• Stress and anxiety regulation

• Cognitive enhancement and learning

• Immune system modulation

• Neuroprotection in preclinical models

Most data comes from animal studies and limited human trials conducted in Russia. Comprehensive global clinical validation is currently lacking.

Proposed Mechanisms of Action (Research Context)

Scientific studies suggest Selank may act through several pathways:

• Modulation of GABAergic and serotonergic neurotransmission, influencing mood and anxiety

• Regulation of brain-derived neurotrophic factor (BDNF), supporting neuroplasticity

• Potential effects on immune signaling, influencing cytokine expression

• Mild anxiolytic and anti-stress activity in preclinical models

It is important to note that these mechanisms are observed primarily in research settings, and direct translation to broad clinical use is not established.

Important Note

This page is provided for educational and research purposes only.

• Selank is not approved for therapeutic, diagnostic, or cosmetic use in the United States or most international jurisdictions.

• Its use outside regulated research or clinical trials is not recommended.